speb/financial-data huggingface dataset:
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 467000000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 492200000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 492200000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 2395900000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2395900000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 261700000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 261700000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Depreciation: 153900000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 371600000.00
CORONA.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 371600000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 100400000.00
CORONA.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 153900000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 100400000.00
CORONA.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 61160088.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 61160088.00
CORONA.NS income_statement (annual, 2025-03-31) — Diluted EPS: 24.43
CORONA.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 5.16
CORONA.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 1494300000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 315500000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 0.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 0.00
CORONA.NS income_statement (annual, 2025-03-31) — EBIT: 2065700000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — EBIT: 458100000.00
CORONA.NS income_statement (annual, 2025-03-31) — EBITDA: 2437300000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — EBITDA: 558500000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 0.00
CORONA.NS cash_flow (annual, 2025-03-31) — End Cash Position: 32200000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1000000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1000000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -1065700000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 885900000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 885900000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 988300000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -200000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 7100000.00
CORONA.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 1201400000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 1711500000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1711500000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 1184200000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1184200000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 4455400000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 4455400000.00
CORONA.NS income_statement (annual, 2025-03-31) — Gross Profit: 9589900000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 2368300000.00
CORONA.NS income_statement (annual, 2025-03-31) — Interest Expense: 80400000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 22000000.00
CORONA.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 80400000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 22000000.00
CORONA.NS income_statement (annual, 2025-03-31) — Interest Income: 44100000.00
CORONA.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 44100000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -99500000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 44100000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Inventory: 1294800000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 1294800000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 6690400000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 6690400000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -838600000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 1100000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 1100000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Investmentsin Associatesat Cost: 258500000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 258500000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 0.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 86400000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 86400000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 210200000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 210200000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 160000000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 160000000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 370200000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 370200000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 0.00
CORONA.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -510000000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 258500000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 258500000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 195200000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 195200000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 1445300000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 1445300000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Net Debt: 594800000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 594800000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -500000.00
CORONA.NS income_statement (annual, 2025-03-31) — Net Income: 1494300000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Net Income: 315500000.00
CORONA.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 1494300000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 315500000.00
CORONA.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 1494300000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 315500000.00
CORONA.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1494300000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 315500000.00
CORONA.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1494300000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 315500000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 1985300000.00
CORONA.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 1494300000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 315500000.00
CORONA.NS income_statement (annual, 2025-03-31) — Net Interest Income: -61900000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -22000000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 27500000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -714400000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -510000000.00
CORONA.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -61900000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -22000000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -1800000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Net PPE: 3925600000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 3925600000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -910200000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -204400000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 4351900000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 4351900000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 0.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 0.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 83000000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 83000000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 190900000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 190900000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 12300000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 12300000.00
CORONA.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 2444800000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 558500000.00
CORONA.NS income_statement (annual, 2025-03-31) — Normalized Income: 1499945116.61
CORONA.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 315500000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 1904900000.00
CORONA.NS income_statement (annual, 2025-03-31) — Operating Income: 2036000000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Operating Income: 441800000.00
CORONA.NS income_statement (annual, 2025-03-31) — Operating Revenue: 11955100000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 2936900000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 61160088.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 61160088.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 1711500000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1711500000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 55700000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 55700000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 60000000.00
CORONA.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 8200000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 14200000.00
CORONA.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 1229400000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 977600000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Other Payable: 125500000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 125500000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Other Properties: 160900000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 160900000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 35700000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 35700000.00
CORONA.NS income_statement (annual, 2025-03-31) — Other Special Charges: 7100000.00
CORONA.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Payables: 1623900000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Payables: 1623900000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 12200000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 12200000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 182600000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 182600000.00
CORONA.NS income_statement (annual, 2025-03-31) — Pretax Income: 1985300000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 436100000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CORONA.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 88300000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: 0.00
CORONA.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -916600000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 261000000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 261000000.00
CORONA.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 2365200000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 568600000.00
CORONA.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 371600000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 100400000.00
CORONA.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 100000.00
CORONA.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 100000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -510000000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 660500000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 660500000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 5036000000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 5036000000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 27500000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 6400000.00
CORONA.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 1299100000.00
CORONA.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 2500500000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Share Issued: 61160088.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 61160088.00
CORONA.NS income_statement (annual, 2025-03-31) — Special Income Charges: -7700000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 6063400000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 6063400000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 4351900000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 4351900000.00
CORONA.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -1854883.39
CORONA.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CORONA.NS income_statement (annual, 2025-03-31) — Tax Provision: 491000000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 120600000.00
CORONA.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.25
CORONA.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.28
CORONA.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 0.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 0.00
CORONA.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -432800000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Total Assets: 9298600000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 9298600000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 6223400000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 6223400000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Total Debt: 862400000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 862400000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 6063400000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 6063400000.00
CORONA.NS income_statement (annual, 2025-03-31) — Total Expenses: 9919100000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 2495100000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 3235200000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3235200000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 5909900000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 5909900000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 839300000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 839300000.00
CORONA.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 25600000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 63200000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 63200000.00
CORONA.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -7500000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
CORONA.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -7500000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Work In Process: 92200000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 92200000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Working Capital: 992800000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 992800000.00
CORONA.NS income_statement (annual, 2025-03-31) — Write Off: 600000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 2194540000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 3462850000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1189880000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1508630000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -564620000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 415840000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -1830000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Amortization: 52200000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 52200000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 60160000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 61160088.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 7.55
CORONA.NS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 32230000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 837270000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -127560000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 233810000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 611600000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 23890000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 23890000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -408180000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Cash Financial: 23890000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Change In Inventory: 110100000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 7630000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 37070000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Change In Payable: -245240000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Change In Receivables: -323540000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -402100000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Changes In Cash: -8400000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Common Stock: 611600000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 6070240000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 2027330000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 657800000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Current Assets: 4094430000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 26500000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Current Debt: 996480000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1022980000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 3279880000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Current Provisions: 275690000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Depreciation: 36980000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 89180000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 89180000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 36980000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 61160088.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 7.55
CORONA.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 461960000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 408180000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — EBIT: 620830000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — EBITDA: 710010000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 60000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — End Cash Position: 23890000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1080000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 1530000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Finished Goods: 835820000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 126110000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -130000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 1690000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 399670000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1659640000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 1510460000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 4603630000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 2805050000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 13900000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 13900000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Interest Income: 14570000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 14570000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -22930000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Interest Received Cfi: 14570000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Inventory: 1190750000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 7136720000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -263600000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 61240000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Investmentsin Associatesat Cost: 256480000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 89900000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 207310000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 70000000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 277310000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -90000000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 256480000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 201980000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 1483320000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Net Debt: 1042590000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -1320000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Net Income: 461960000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 461960000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 461960000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 461960000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 461960000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 606930000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 461960000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -5310000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -153280000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 439530000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -90000000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -5310000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Net PPE: 4039010000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -124890000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 529530000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 4410600000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 0.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 82160000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 212180000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 12420000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 711780000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 463307221.59
CORONA.NS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 253670000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Operating Income: 610510000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 3462850000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 61160088.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1659640000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Other Inventories: 56680000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 5200000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 3410000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 400160000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Other Payable: 220880000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Other Properties: 165810000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Other Receivables: 109300000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Other Special Charges: 1690000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Payables: 1962040000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 13560000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 99690000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 606930000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 15240000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -153280000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -127560000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Raw Materials: 215390000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 657800000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 89180000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Rent And Landing Fees: 50000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 50000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -90000000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 1162170000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 5042800000.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
CORONA.NS cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 2670000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 333640000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 733310000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Share Issued: 61160088.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: -1900000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 6070240000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 4410600000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -422778.41
CORONA.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 144970000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.24
CORONA.NS cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -63200000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Total Assets: 10123750000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 6140240000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Total Debt: 1300290000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 6070240000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 2852340000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 4053510000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 6029320000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 773630000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 5980000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 143100000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: -1770000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -1770000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Work In Process: 82860000.00
CORONA.NS balance_sheet (quarterly, 2025-06-30) — Working Capital: 814550000.00
CORONA.NS income_statement (quarterly, 2025-06-30) — Write Off: 210000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 2084400000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 3424200000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 61140741.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 6.75
CORONA.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 602700000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 94500000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 94500000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 61140741.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 6.75
CORONA.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 412700000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — EBIT: 568700000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — EBITDA: 663200000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 2821500000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 16600000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 16600000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Net Income: 412700000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 412700000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 412700000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 412700000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 412700000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 412700000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -16600000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -16600000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 854200000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 555474316.25
CORONA.NS income_statement (quarterly, 2025-12-31) — Operating Income: 737100000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 3424200000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 22400000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1030500000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Other Special Charges: 191000000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 552100000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 602700000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 94500000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -191000000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -48225683.75
CORONA.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 139400000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
CORONA.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 2687100000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -191000000.00
CORONA.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -191000000.00
CORONA.NS income_statement (annual, 2026-03-31) — +Operating Expense: 8842500000.00
CORONA.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 2351200000.00
CORONA.NS income_statement (annual, 2026-03-31) — +Total Revenue: 14014800000.00
CORONA.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 3530900000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 1470700000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1470700000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 1455500000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1455500000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -682000000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -682000000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 415800000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 415800000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1800000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1800000.00
CORONA.NS income_statement (annual, 2026-03-31) — Amortization: 217000000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 217000000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 1266500000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 1266500000.00
CORONA.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 61160088.00
CORONA.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 61174089.00
CORONA.NS income_statement (annual, 2026-03-31) — Basic EPS: 30.27
CORONA.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 7.41
CORONA.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 32200000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 1162000000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 1162000000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1741400000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 219900000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 219900000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 611600000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 611600000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 18300000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 18300000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 18300000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 18300000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -447100000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 18300000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 18300000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 52100000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -118700000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -18000000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Change In Payable: 37100000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -260700000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -58700000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -13900000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Common Stock: 611600000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 611600000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 7468600000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 7468600000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 1466900000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 1466900000.00
CORONA.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 2609400000.00
CORONA.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 662400000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Current Assets: 3483100000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 3483100000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 31100000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 31100000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Current Debt: 1428600000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 1428600000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 1459700000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1459700000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 3611700000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 3611700000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 307200000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 307200000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Depreciation: 161700000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 378700000.00
CORONA.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 378700000.00
CORONA.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 102900000.00
CORONA.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 161700000.00
CORONA.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 102900000.00
CORONA.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 61160088.00
CORONA.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 61174089.00
CORONA.NS income_statement (annual, 2026-03-31) — Diluted EPS: 30.27
CORONA.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 7.41
CORONA.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 1851200000.00
CORONA.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 453300000.00
CORONA.NS income_statement (annual, 2026-03-31) — EBIT: 2449900000.00
CORONA.NS income_statement (quarterly, 2026-03-31) — EBIT: 561200000.00
CORONA.NS income_statement (annual, 2026-03-31) — EBITDA: 2828600000.00
CORONA.NS income_statement (quarterly, 2026-03-31) — EBITDA: 664100000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 0.00
CORONA.NS cash_flow (annual, 2026-03-31) — End Cash Position: 18300000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1600000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1600000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 252800000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 833800000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 833800000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 553400000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -700000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 5400000.00
CORONA.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 1403800000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 2628300000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2628300000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 1457300000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 1457300000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 5060300000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 5060300000.00
CORONA.NS income_statement (annual, 2026-03-31) — Gross Profit: 11405400000.00
CORONA.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 2868500000.00
CORONA.NS income_statement (annual, 2026-03-31) — Interest Expense: 45700000.00
CORONA.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 13800000.00
CORONA.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 45700000.00
CORONA.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 13800000.00
CORONA.NS income_statement (annual, 2026-03-31) — Interest Income: 70600000.00
CORONA.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 70600000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -73900000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 70600000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Inventory: 1250000000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 1250000000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 8897200000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 8897200000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -2561500000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 1268100000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 1268100000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Investmentsin Associatesat Cost: 261200000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Investmentsin Associatesat Cost: 261200000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 89900000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 89900000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 188800000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 188800000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 0.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 0.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 188800000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 188800000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -360000000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 261200000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 261200000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 232800000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 232800000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 2144500000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 2144500000.00
CORONA.NS balance_sheet (annual, 2026-03-31) — Net Debt: 1410300000.00
CORONA.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 1410300000.00
CORONA.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -12500000.00
CORONA.NS income_statement (annual, 2026-03-31) — Net Income: 1851200000.00
CORONA.NS income_statement (quarterly, 2026-03-31) — Net Income: 453300000.00
CORONA.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 1851200000.00
CORONA.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 453300000.00
CORONA.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 1851200000.00